Section II: Object
II.1)Scope of the procurement
II.1.1)Title:
Contratación del Suministro de Medicamentos con destino a los Servicios de Farmacia de los Hospitales sitos en Majadahonda, Sevilla y Barcelona de FREMAP
Reference number: LICT/99/114/2019/0033
II.1.2)Main CPV code
33600000 Pharmaceutical products
II.1.3)Type of contract
Supplies
II.2)Description
II.2.1)Title:
Contratación del suministro de Sugammdex, Raltegravir, Rocuronio,Betametasona Acetato /Betametasna Fosfato Sodico, Betametasona /Gentamicina, Betametasona y Ertapenem
Lot No: 2
II.2.2)Additional CPV code(s)
33600000 Pharmaceutical products
II.2.3)Place of performance
NUTS code: ES España
Main site or place of performance:
II.2.4)Description of the procurement at the time of conclusion of the
contract:
Contratación del suministro de Sugammdex, Raltegravir, Rocuronio,Betametasona Acetato /Betametasna Fosfato Sodico, Betametasona /Gentamicina, Betametasona y Ertapenem
II.2.7)Duration of the contract, framework agreement, dynamic purchasing system or
concession
Duration in months: 48
II.2.13)Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds: no
Section V: Award of contract/concession
Title:
Contratación del suministro de Sugammdex, Raltegravir, Rocuronio,Betametasona Acetato /Betametasna Fosfato Sodico, Betametasona /Gentamicina, Betametasona y Ertapenem
V.2)Award of contract/concession
V.2.1)Date of conclusion of the contract/concession award decision:
23/09/2019
V.2.2)Information about tenders
The contract/concession has been awarded to a group of economic operators: no
V.2.3)Name and address of the contractor/concessionaire
Official name: MERCK SHARP & DOHME SA
National registration number: A28211092
Town: ESPAÑA
NUTS code: ES España
Country: Spain
The contractor/concessionaire is an SME: no
V.2.4)Information on value of the contract/lot/concession (at the time of conclusion
of the contract;excluding VAT)
Total value of the procurement: 465 476.43 EUR
Section VI: Complementary information
VI.3)Additional information:
VI.4)Procedures for review
VI.4.1)Review body
Official name: Tribunal Administrativo Central de Recursos Contractuales
Town: Madrid
Country: Spain
VI.5)Date of dispatch of this notice:
15/12/2023
Section VII: Modifications to the contract/concession
VII.1)Description of the procurement after the modifications
VII.1.1)Main CPV code
33600000 Pharmaceutical products
VII.1.2)Additional CPV code(s)
VII.1.3)Place of performance
NUTS code: ES España
Main site or place of performance:
Majadahonda, Sevilla y Barcelona
VII.1.4)Description of the procurement:
Contratación del suministro de Sugammdex, Raltegravir, Rocuronio,Betametasona Acetato /Betametasna Fosfato Sodico, Betametasona /Gentamicina, Betametasona y Ertapenem
VII.1.5)Duration of the contract, framework agreement, dynamic purchasing system or
concession
Duration in months: 48
VII.1.6)Information on value of the contract/lot/concession (excluding VAT)
Total value of the contract/lot/concession: 465 476.43 EUR
VII.1.7)Name and address of the contractor/concessionaire
Official name: MERCK SHARP & DOHME SA
National registration number: A28211092
Postal address: Calle Josefa Valcarcel N38
Town: Madrid
NUTS code:
ES España
Postal code: 28027
Country: Spain
E-mail:
cristina.beltran@merck.com
Telephone: +91 3210557
The contractor/concessionaire is an SME: no
VII.2)Information about modifications
VII.2.1)Description of the modifications
Nature and extent of the modifications (with indication of possible earlier changes to the contract):
El incremento de intervenciones quirúrgicas es debido por un lado al aumento de trabajadores protegidos por FREMAP cifrado en 3,94 por cierto y por otro lado al aumento exponencial
de la siniestralidad laboral. Estos datos traen como consecuencia más inmediata el aumento de las intervenciones quirúrgicas y por tanto de los medicamentos necesarios para la
realización de estas en unas condiciones óptimas para el paciente por parte del personal de FREMAP.
VII.2.2)Reasons for modification
Need for modification brought about by circumstances which a diligent contracting authority/entity could not foresee (Art. 43(1)(c) of Directive 2014/23/EU, Art. 72(1)(c) of Directive
2014/24/EU, Art. 89(1)(c) of Directive 2014/25/EU)
Description of the circumstances which rendered the modification necessary and explanation of the unforeseen nature of these circumstances:
Estos medicamentos objeto del contrato que se pretende modificar son empleados en la práctica anestésica para prevenir el dolor durante una cirugía y otros procedimientos
provocando una pérdida de la sensibilidad o la conciencia
VII.2.3)Increase in price
Updated total contract value before the modifications (taking into account possible earlier contract modifications and price adaptions and, in the case of Directive 2014/23/EU,
average inflation in the Member State concerned)
Value excluding VAT: 465 476.43 EUR
Total contract value after the modifications
Value excluding VAT: 520 542.54 EUR